DNA Capital
São Paulodnacapital.com
Overview
DNA Capital is a global healthcare investment firm that partners with early to late-stage companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Sanar | Mar 2025 | Early Funding | Co-investor |
| Reema Health | Oct 2024 | Series A | Co-investor |
| HuHu AI | Jun 2023 | Pre Seed | Co-investor |
| Beep Saúde | Nov 2022 | Series C | Co-investor |
| Sanar | May 2022 | Strategic | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.